Skip to content

Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients

Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04252651
Enrollment
65
Registered
2020-02-05
Start date
2019-10-02
Completion date
2022-12-31
Last updated
2021-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis, Inflammatory Response, Multi Organ Failure, Nosocomial Infection

Brief summary

This study will involve blood draws to test for specific cytokines. The study goal is to gain a better understanding of the role of inflammatory response in the development of specific complications in burn and TENS patients.

Interventions

OTHERBlood Draw

This study will involve blood draws to test for specific cytokines

Sponsors

Joseph M. Still Research Foundation, Inc.
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* is ≥18 years of age * has been admitted to the Joseph M. Still Burn Center at Doctors Hospital Augusta with a burn diagnosis, or TENS OR SJS diagnosis (confirmed or non-confirmed), with an expected length of stay to be at least 7 days * the subject or their legally authorized representative is able to provide informed consent * has a negative urine or serum pregnancy test at screening (if female and has potential for pregnancy)

Exclusion criteria

* is moribund, or in the opinion of the investigator is not expected to survive * has sustained an electrical burn

Design outcomes

Primary

MeasureTime frameDescription
Cytokine Response that develops into complicationsup to one yearThe number of burn and TENS patients that develop subsequent medical complications

Countries

United States

Contacts

Primary ContactJoan Wilson
joan.wilson@jmsresearchfoundation.org7063642966

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026